Filing Details
- Accession Number:
- 0001127602-16-055579
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-15 16:03:29
- Reporting Period:
- 2016-06-13
- Filing Date:
- 2016-06-15
- Accepted Time:
- 2016-06-15 16:03:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1275654 | P David King | 531 South Spring Street Burlington NC 27215 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-06-13 | 123,839 | $70.15 | 271,210 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-06-13 | 73,455 | $127.76 | 197,755 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-06-13 | 45,884 | $128.79 | 151,871 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-06-13 | 4,500 | $129.47 | 147,371 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2016-06-13 | 72,561 | $70.15 | 219,932 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-06-13 | 72,561 | $127.65 | 147,371 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Options | Disposition | 2016-06-13 | 123,839 | $0.00 | 123,839 | $70.15 |
Common Stock | Non-qualified Stock Options | Disposition | 2016-06-13 | 72,561 | $0.00 | 72,561 | $70.15 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
72,561 | 2011-02-09 | 2020-02-09 | No | 4 | M | Direct |
0 | 2011-02-09 | 2020-02-09 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 24,383 | Indirect | By grantor retained annuity trust |
Common Stock | 19,046 | Indirect | By grantor retained annuity trust |
Footnotes
- Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
- The price of $127.7622 per share represents a weighted average of sales prices ranging from $127.36 to $128.35 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- The price of $128.7945 per share represents a weighted average of sales prices ranging from $128.36 to $129.35 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- The price of $129.4724 per share represents a weighted average of sales prices ranging from $129.36 to $129.72 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- The price of $127.6463 per share represents a weighted average of sales prices ranging from $127.43 to $128.14 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.
- The option vested in three equal annual installments beginning on 02/09/2010 and is now fully exercisable.